Markovic, M., Ben-Shabat, S., Manda, J. N., Abramov-Harpaz, K., Regev, C., Miller, Y., . . . Dahan, A. (2022). PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy. Pharmaceutics, 14(3), 675. https://doi.org/10.3390/pharmaceutics14030675

Markovic, Milica, Shimon Ben-Shabat, Jagadeesh Nagendra Manda, Karina Abramov-Harpaz, Clil Regev, Yifat Miller, Aaron Aponick, Ellen M. Zimmermann, and Arik Dahan. "PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy." Pharmaceutics 14, no. 3 (2022): 675. https://doi.org/10.3390/pharmaceutics14030675.

Markovic, Milica, et al. "PLA2-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy." Pharmaceutics, vol. 14, no. 3, 2022, p. 675, https://doi.org/10.3390/pharmaceutics14030675.